vaccine

GSK Seeks Regulatory Approval to Extend RSV Vaccination to At-Risk Adults Aged 50-59

(IN BRIEF) GSK has submitted a regulatory application to the European Medicines Agency (EMA) to expand the use of its…

3 months ago

BioNTech Inaugurates mRNA Vaccine Manufacturing Site in Rwanda, Aims to Boost Vaccine Equity in Africa

(IN BRIEF) BioNTech has achieved a significant milestone in expanding mRNA vaccine manufacturing in Africa with the inauguration of its…

5 months ago

Sanofi Collaborates with Janssen on Vaccine for Extraintestinal Pathogenic E. coli

(IN BRIEF) Sanofi has entered into an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, to develop and…

7 months ago

EMA Backs Comirnaty Omicron XBB.1.5 Vaccine for Varied Ages Amid Variant Concerns

(IN BRIEF) EMA proposes Comirnaty Omicron XBB.1.5 vaccine for ages 6 months+, tailored to combat Omicron XBB.1.5 variant. One dose…

8 months ago

WACKER and CordenPharma joint bid to become part of Germany’s Pandemic Preparedness Plan has been accepted

(PRESS RELEASE) MUNICH/ HALLE, PLANKSTADT, 11-Apr-2022 — /EuropaWire/ — WACKER Group (ETR: WCH), a German multinational chemical company, and CordenPharma,…

2 years ago

NIHR funded project that involves Universities of East Anglia, Leicester and Liverpool to help reduce the number of cases of flu in care homes

(PRESS RELEASE) LIVERPOOL, 21-Sep-2021 — /EuropaWire/ — University of Liverpool, one of the six original 'red brick' civic universities, has…

3 years ago

AstraZeneca, EU agree to end legal proceedings over the delivery of the COVID-19 vaccine Vaxzevria

(PRESS RELEASE) CAMBRIDGE, 3-Sep-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical and biopharmaceutical company, has announced an…

3 years ago

COVID-19 Vaccine AstraZeneca confirmed safe and effective at preventing COVID-19

Increased efficacy with longer inter-dose interval Protection of over 70% starting after a first dose First indication of reduction in…

3 years ago

Flu vaccination campaign by the CERN Medical Service will begin on 2 November until 4 December 2020

(PRESS RELEASE) GENEVA, 26-Oct-2020 — /EuropaWire/ — CERN Medical Service, CERN's unit responsible for the Organization's occupational health & safety,…

4 years ago

The COVID-19 vaccine based on Sanofi’s recombinant protein-based technology and GSK’s pandemic adjuvant system secures 300 million doses order from the European Commission (EC)

Agreement signed today supports scale-up of manufacturing capabilities in several European countries Vaccine candidate uses Sanofi’s recombinant protein-based technology combined…

4 years ago

New EU / AstraZeneca deal to help EU member states access the AZD1222 COVID-19 vaccine at no profit during the pandemic

(PRESS RELEASE) CAMBRIDGE, 14-Aug-2020 — /EuropaWire/ — Global science-led biopharmaceutical company AstraZeneca (LSE/STO/NYSE: AZN) has announced it signed an agreement…

4 years ago

AstraZeneca expects to begin first deliveries of the University of Oxford’s vaccine in September 2020

The company received support of more than $1bn from the US Biomedical Advanced Research and Development Authority (BARDA) Broad and…

4 years ago

Atos provides solutions and computing power to help with the global fight against Covid-19

(PRESS RELEASE) PARIS, 28-Apr-2020 — /EuropaWire/ — Digital transformation leader, Atos brings its technology leadership, skills and innovation resources to…

4 years ago

Wellcome supports rapid response to the new Ebola outbreak in Congo with initial fund of up to £2 million

LONDON, 14-May-2018 — /EuropaWire/ — Wellcome is making an initial fund of up to £2 million available to support a…

6 years ago

University of York: Breakthrough in the search for an effective vaccine for the neglected tropical disease leishmaniasis

Scientists say they have made a major breakthrough in the search for an effective vaccine for the neglected tropical disease…

7 years ago

University of East Anglia and the University of Leeds: Informing parents about the measles mumps and rubella (MMR) vaccine is the most cost-effective way of increasing its uptake

Norwich, UK, 28-7-2014 — /EuropaWire/ — Giving parents access to online information about the MMR vaccine is the most cost-effective way of…

10 years ago